Benidipine
- Generic Name
- Benidipine
- Drug Type
- Small Molecule
- Chemical Formula
- C28H31N3O6
- CAS Number
- 105979-17-7
- Unique Ingredient Identifier
- 4G9T91JS7E
- Background
Benidipine has the formula 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid methyl 1-(phenylmethyl)-3-piperidinyl ester hydrochloride. It is a synthetic dihydropyridine derivative that has anti-hypertensive and anti-anginal actions. It was originated in Japan by Kyowa Hakko, it is submitted for FDA approval and it is currently available in some Asian countries like India and Japan.
- Indication
Benidipine is a potent and long-lasting drug indicated for the treatment of cardiovascular diseases such as hypertension, renoparenchymal hypertension and angina pectoris.
- Associated Conditions
- Angina Pectoris, Hypertension, Hypertension, Renal, Renal parenchymal hypertension
Benidipine in Hypertensive And/or Chronic Coronary Syndrome Patients
- Conditions
- Chronic Coronary SyndromeHypertensionAngina Pectoris
- First Posted Date
- 2025-02-05
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- The Society of Prevention and Awareness of Cardiovascular Diseases
- Target Recruit Count
- 800
- Registration Number
- NCT06808321
Benidipine and Hydrochlorothiazide in Fosinopril Treated Chronic Kidney Disease Patients With Hypertension
- Conditions
- Chronic Kidney Disease
- Interventions
- First Posted Date
- 2016-01-05
- Last Posted Date
- 2016-01-05
- Lead Sponsor
- Shanghai Changzheng Hospital
- Target Recruit Count
- 508
- Registration Number
- NCT02646397
- Locations
- 🇨🇳
Department of Nephrology, Shanghai Changzheng Hospital, Shanghai, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.